The findings of this study suggest that GPE could be a promising nutraceutical candidate for gastric cancer prevention due to its selective cytotoxicity toward cancer cells and its ability to modulate multiple signaling pathways involved in tumor progression. The gene discussed is GYPE; the disease is gastric cancer.